From April 2023, everyone with HIV who is older than four weeks (and who weighs more than three kilograms) will be able to go on a treatment plan that includes the antiretroviral (ARV) drug, dolutegravir, according to Thato Chidarikire, the health department's acting head of HIV programmes.
